Document is current
Any future updates will be listed below
-
Authors
Siehler, Johanna
Bilekova, Sara https://orcid.org/0000-0001-6699-1386
Chapouton, Prisca https://orcid.org/0000-0002-5281-153X
Dema, Alessandro
Albanese, Pascal https://orcid.org/0000-0002-0940-8534
Tamara, Sem https://orcid.org/0000-0002-6062-9404
Jain, Chirag
Sterr, Michael
Enos, Stephen J. https://orcid.org/0000-0003-1026-1418
Chen, Chunguang
Malhotra, Chetna
Villalba, Adrian https://orcid.org/0000-0003-3148-5453
Schomann, Leopold https://orcid.org/0009-0008-6716-1753
Bhattacharya, Sreya https://orcid.org/0009-0001-8666-9383
Feng, Jin https://orcid.org/0000-0001-7265-0051
Akgün Canan, Melis
Ribaudo, Federico
Ansarullah, https://orcid.org/0000-0002-3415-7319
Burtscher, Ingo
Ahlbrecht, Christin
Plettenburg, Oliver https://orcid.org/0000-0001-9671-278X
Kurth, Thomas https://orcid.org/0000-0001-5624-1717
Scharfmann, Raphael https://orcid.org/0000-0001-7619-337X
Speier, Stephan https://orcid.org/0000-0002-4561-7085
Scheltema, Richard A. https://orcid.org/0000-0002-1668-0253
Lickert, Heiko https://orcid.org/0000-0002-4597-8825
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 7 October 2024
First Online: 25 November 2024
Competing interests
: H.L. is the inventor of the patent ‘Novel IGFR-like receptor and uses thereof’ held by the Helmholtz Zentrum München (WO2017042242) and co-inventor of the pending patent application filed by the Helmholtz Zentrum München ‘Novel IGFR-like 1 monoclonal antibodies and uses thereof’ (WO2023002060). The other authors declare no competing interests.
